Genedata, a Danaher Corporation company, announced the release of a new Sample Management module as part of its Genedata Biopharma Platform. This solution is designed to advance R&D efficiency for biopharmaceutical companies.
The new module provides a unified approach to sample management, covering the entire end-to-end workflow from therapeutics design and engineering to process development. This integration aims to streamline operations and improve data quality.
By offering a comprehensive platform, Genedata supports a broad range of therapeutic modalities. This enhancement reinforces Danaher's commitment to providing leading enterprise software solutions that accelerate drug discovery and development.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.